International trial using ipilimumab and nivolumab to treat patients with advanced melanoma stopped cancer advancing in 58% of cases
Terminally ill cancer patients could be “effectively cured” of the disease using a powerful new combination of drugs described by scientists as heralding a once-in-a-generation advance in treatment.
A British-led trial brought “spectacular” results with more than half of patients with advanced melanoma seeing tumours shrink or brought under control using the drugs.
Continue reading...
No comments:
Post a Comment